Posts tagged EpiPen
HCW starts Antares Pharma at buy

H.C. Wainwright initiated coverage of Antares Pharma (NASDAQ:ATRS) with a “buy” rating and $5 price target. The stock closed at $3.01 on June 22.

Read More